Journal
GYNECOLOGICAL ENDOCRINOLOGY
Volume 37, Issue 6, Pages 497-505Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/09513590.2020.1843619
Keywords
Alpha lipoic acid; endometriosis; infertility; male factor; polycystic ovary syndrome
Ask authors/readers for more resources
Alpha lipoic acid (ALA) shows beneficial effects in the treatment of female and male infertility, promoting oocyte maturation, improving fertilization and embryo development, and enhancing reproductive outcomes. Regular administration of ALA can also reduce pelvic pain in endometriosis patients, regulate menstrual flow and metabolic disorders, and improve sperm quality.
Objective Infertility is an increasingly frequent health condition, which may depend on female or male factors. Oxidative stress (OS), resulting from a disrupted balance between reactive oxygen species (ROS) and protective antioxidants, affects the reproductive lifespan of men and women. In this review, we examine if alpha lipoic acid (ALA), among the oral supplements currently in use, has an evidence-based beneficial role in the context of female and male infertility. Methods We performed a search from English literature using PubMed database with the following keywords: 'female infertility', 'male infertility', 'semen', 'sperm', 'sub-fertile man', 'alpha-lipoic acid', ' alpha lipoic acid', 'lipoid acid', 'endometriosis', 'chronic pelvic pain', 'follicular fluid' and 'oocytes'. We included clinical trials, multicentric studies and reviews. The total number of references found after automatically and manually excluding duplicates was 180. After primary and secondary screening, 28 articles were selected. Results The available literature demonstrates the positive effects of ALA in multiple processes from oocyte maturation (0.87 +/- 0.9% of oocyte in MII vs 0.81 +/- 3.9%; p < .05) to fertilization, embryo development (57.7% vs 75.7% grade 1 embryo; p < .05) and reproductive outcomes. Its regular administration both in sub-fertile women and men shows to reduce pelvic pain in endometriosis (p < .05), regularize menstrual flow and metabolic disorders (p < .01) and improve sperm quality (p < .001). Conclusions ALA represents a promising new molecule in the field of couple infertility. More clinical studies are needed in order to enhance its use in clinical practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available